<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00929318</url>
  </required_header>
  <id_info>
    <org_study_id>MHH-THY-WH-09</org_study_id>
    <nct_id>NCT00929318</nct_id>
  </id_info>
  <brief_title>Influence of Thyroid Hormones on the Woundhealing Process</brief_title>
  <official_title>Clinical Investigations on Cytokin-Gradients in Hypo/Euthyroid Patients. Evaluation of Expression of Different Pro-and Anti-Inflammatory Cyto-/Chemokines in Skin Wounds After Surgery of Benign Goitres (Struma Multinodosa) or Malignant Diseases of Thyroid Gland (Papillary Thyroid Carcinoma) in Correlation to the Status of Wound Healing of the Neck Wound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Genzyme, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main goal of this clinical investigation is to investigate different cytokines in wound
      fluids of euthyroid vs. hypothyroid patients. As a primary endpoint we want to evaluate if
      different cytokine levels in euthyroid vs. hypothyroid patients exist and to what extent
      these cytokines differ. Our targeted cytokines are: IL6, IL10, TNFa and MCP-1. From the
      literature these 4 factors seem to be the most reasonable to measure and to focus on.
      Additionally we focus on these 4 factors for financial reasons, technically there wouldn't be
      a problem to measure more, which is correlated with higher costs. Besides, more than 6
      factors would mean larger amounts of sample fluids needed, which would cause technical
      problems. These factors don`t have to change in the same direction. Secondarily, we believe
      that differences in cytokine profiles of hypothyroidism vs. euthyroidism will correlate to
      differences in duration and clinical characteristics of the wound healing process.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence for different cytokine levels in euthyroid vs hypothyroid condition confirmed by bood serum samples</measure>
    <time_frame>21 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in duration and clinical characteristics of the wound healing process verified by a modified ASEPSIS score.</measure>
    <time_frame>21 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Thyroid Neoplasms</condition>
  <condition>Thyroid Carcinoma</condition>
  <arm_group>
    <arm_group_label>benign</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients after surgery because of a benign disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DTC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients after thyroidectomy because of papillary carcinoma of the thyroid gland</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <arm_group_label>benign</arm_group_label>
    <arm_group_label>DTC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <arm_group_label>benign</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Near total or total thyroidectomy because of struma multinodsa (nodular goiter) with
             or without substitution of thyroid hormone after operation

          -  Total thyroidectomy because of papillary carcinoma of thyroid gland (T1/T2 carcinoma,
             N1, M0) with planned radio-ablative therapy (RAT) without or with rhTSH

        Exclusion Criteria:

          -  Pat&lt; 18 years

          -  Immune disease of thyroid gland (Graves disease)

          -  Severe immunodeficiency

          -  Immunosuppressive medication because of solid Organ transplantation

          -  Hepatitis A/B/C or HIV

          -  All exclusion criteria for any surgical procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephan S Kaaden, Dr</last_name>
    <phone>0049-511-532 6131</phone>
    <email>Kaaden.Stephan@mh-hannover.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georg FW Scheumann, Prof</last_name>
    <phone>0049-511-532 2032</phone>
    <email>scheumann.georg@mh-hannover.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medizinische Hoochschule Hannover, Allgemein-, Viszeral-und Transplantationscirurgie OE 6220</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Kaaden, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Stephan Kaaden, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2009</study_first_submitted>
  <study_first_submitted_qc>June 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2009</study_first_posted>
  <last_update_submitted>June 26, 2009</last_update_submitted>
  <last_update_submitted_qc>June 26, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr Georg FW Scheumann</name_title>
    <organization>Medizinische Hochschule Hannover</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

